Prof Wolfson Institute of Population Health, QMUL; Consultant Gynae-Oncologist Barts Health NHS Trust; Hon Prof LSHTM; Precision Prevention in Women’s Cancers
Hear expert perspectives on prevention and early detection from invited speakers Barbara Norquist, MD, of University of Washington, and Ranjit Manchanda, MD, MRCOG, PhD, of Queen Mary University of London.
Learn from them and other ovarian cancer researchers at the 16th Biennial Rivkin Ovarian Cancer Research Symposium, Oct. 16-18, 2026. The Symposium also fosters networking and collaboration through poster sessions, breakout discussions, and career development opportunities. Register today: https://t.co/1FobXUdi4N
@BarbNorquist@ProfManchanda@LondonU@QMUL@UW
Which workshop will you choose? 🤓
Register early for #ESGO2027 in London 🇬🇧 to:
🔸 claim a spot at your favourite workshop
🔸 secure free childcare
🔸 access the early registration discounts!
#gynonc
Health-related quality of life after risk-reducing #hysterectomy (PRESCORES): a cross-sectional study
Health-related quality-of-life in women with #LynchSyndrome is likely to be lower following RRH in younger, pre-menopausal women
https://t.co/xFvTVfGUUZ
https://t.co/Z8Z3ObacFU
Delighted to see our PRESCORES paper put in Eclinicalmedicine @eClinicalMed
Risk Reducing Hysterectomy has a QOL detriment in premenopausal but not post menopausal women with Lynch Syndrome
Significant reduction in cancer worry overall
A population-based digital study offering people testing for cancer genes, to identify people at increased risk of cancer so they can take steps to prevent it or detect it early. The PROTECT-C Study registered at #ISRCTN by @ProfManchanda
https://t.co/EZEA7gFSlu
#clinicaltrials
https://t.co/kAs0L1q8BK
Good to see the coverage of the NHS JBRCA programme in the JC, highlighting its importance, outreach and benefit. Thx to the huge number of community and professional stakeholders who have supported it. thx to NHSE for the continued support.
A great time was had by the #WPP_team at our 2025 Christmas party! There have been many wonderful achievement this year; with PhDs, clinical fellowships, Grants, publications and much more to celebrate!
Many thanks to Ranjit Manchanda and to Vic White for organising the party.
Our paper ‘Consent model for tumour genetic testing in ovarian cancer’ shows strong support for reflex tumour genetic testing. Most patients, physicians, and charity representatives favoured testing without explicit consent, alongside an opt-out option. https://t.co/VCMQOkx5mW
Congratulations to our WPP member Priyanka Deshmukh on being awarded PPI grant of £966 from the QMUL Centre for Public Engagement. This PPI work will help inform the design of a future project ‘LEGACY – Lynch Evaluation for Genetic Analysis and Cascade testing in Years past’.
Please join us for our monthly webinar on Wed 17th December at 3 pm UK time. This month's topic is a session on 'New Entities Identified Through Referral Practice' with Prof Glenn McCluggage. Free to register @ https://t.co/mWdwBiPq4J #PathTwitter#GynPath#Gynaepath
@ProfManchanda speaks at the 9th European Tumour Hereditary Group meeting held in Heidelberg in September. He had a keynote presentation on population screening strategies and implications of the PROTECTOR study and presented abstracts of findings from our PRESCORES study.
https://t.co/MYBhnj8drb
Great to see our paper out on PPOSSUM score for predicting morbidity in Ovarian cancer cytoreductive surgery.
We show it is a poor predictor and should not be used.